Population
52 youth-onset type 2 diabetes participants enrolled in clinical trials between 2021-2025, mean age 17.0±4.4…
Design
Cohort
Follow-up
7-10 days
Key result
In youth-onset type 2 diabetes, glycemic variability was high and correlated with HbA1c, while insulin therapy was associated with higher glucose standard deviation (46 vs. 24 mg/dL, P<0.01).
Authors
Loading...
GV assessment may aid risk stratification in Y-T2D on insulin; leaves open whether targeting variability improves CVD outcomes.
Cohort (n=52)
Youth-onset type 2 diabetes is associated with high day-to-day glycemic variability, which correlates with HbA1c and is highest in patients on insulin therapy, highlighting a potential independent risk factor for cardiovascular disease.
Rangos et al. (2026) conducted a cohort in Youth-onset type 2 diabetes (n=52). Glycemic variability was evaluated on Glycemic variability (SD and MODD) and its relationship with HbA1c. In youth-onset type 2 diabetes, glycemic variability was high and correlated with HbA1c, while insulin therapy was associated with higher glucose standard deviation (46 vs. 24 mg/dL, P<0.01).